CLINICAL TRIALS PROFILE FOR JNJ-42165279
✉ Email this page to a colleague
Clinical Trials for JNJ-42165279
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT01650597 ↗ | A Single Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-42165279 in Healthy Male Participants | Completed | Janssen-Cilag International NV | Phase 1 | The purpose of this study is to investigate the safety, tolerability and pharmacokinetics of single ascending doses as well as repeated doses of JNJ-42165279 in healthy male participants. |
NCT01826786 ↗ | The Effects of JNJ-42165279 on the Neural Basis of Anxiety Disorders in Healthy Male Volunteers | Completed | Janssen Research & Development, LLC | Phase 1 | The purpose of this study is to evaluate the potential efficacy of JNJ-42165279 in treating anxiety disorders through evaluation of brain activation patterns using imaging technology in healthy volunteers. |
NCT01964651 ↗ | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-42165279 in Healthy Young and Elderly Participants | Completed | Janssen Research & Development, LLC | Phase 1 | The purpose of this study is to assess the safety, tolerability, and pharmacokinetics of JNJ-42165279 in healthy, young and elderly, male and female participants after repeated oral dose administration. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for JNJ-42165279
Condition Name
Clinical Trial Locations for JNJ-42165279
Trials by Country
Clinical Trial Progress for JNJ-42165279
Clinical Trial Phase
Clinical Trial Sponsors for JNJ-42165279
Sponsor Name